| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $28.5M | +6.9% | -1.8% |
| R&D Expense | $969K | +5.8% | -31.1% |
| SG&A Expense | $3.7M | +3.1% | -2.6% |
| Operating Income | -$7.6M | -1962.4% | -283.3% |
| Pre-tax Income | -$6.9M | -768.4% | -502.6% |
| Income Tax | $16K | -84.8% | -68.6% |
| Net Income | -$6.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $72.8M | +30.2% | +405.7% |
| Accounts Receivable | $24.3M | -4.1% | -1.8% |
| Inventory | $13.4M | -33.9% | -46.9% |
| Current Assets | $119.7M | -2.7% | -9.1% |
| Total Assets | $150.3M | -1.2% | -9.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $13.7M | — | — |
| Capital Expenditures | $5.0M | — | — |
| Investing Cash Flow | $9.8M | — | — |
| Financing Cash Flow | -$1.3M | — | — |
| Free Cash Flow | $8.7M | — | — |
| -845.6% |
| -478.3% |
| EPS (Basic) | -$0.36 | -820.0% | -500.0% |
| EPS (Diluted) | -$0.36 | -820.0% | -500.0% |
| $15.2M |
| +16.2% |
| -35.6% |
| Total Liabilities | $19.2M | +40.8% | -19.9% |
| Stockholders' Equity | $131.0M | -5.3% | -8.2% |